Ocera Therapeutics, Inc. (NASDAQ:OCRX)

CAPS Rating: 3 out of 5

OCRX News and Commentary

Caps

How do you think OCRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

43 Outperform
3 Underperform
 

All-Star Players

13 Outperform
2 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top OCRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.81)
Submitted February 20, 2015

Ocera provided one of those interesting plays in the after hours on Thursday where the stock is down on disappointing data, but it's not the important data. The company reported results from a Spanish investigator-sponsored trial of ornithine… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

OCRX VS S&P 500 (SPY)

OCRX Summary

Fools bullish on OCRX are also bullish on:

Fools bearish on OCRX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about OCRX.

Recs

0
Member Avatar oscillation (72.53) Submitted: 2/2/2017 1:40:00 PM : Outperform Start Price: $0.62 OCRX Score: +77.72

nev

Recs

0
Member Avatar biotechf (25.45) Submitted: 3/31/2015 2:26:33 AM : Outperform Start Price: $4.88 OCRX Score: -96.38

The company's STOP-HE phase IIb trial in acute hepatic encephalopathy is due to have topline data reported by the end of 2015. Look for enrollment of the trial to be complete in mid 2015. Both of these events should be catalysts for the stock with the topline data being make or break.

Recs

0
Member Avatar TMusta (60.51) Submitted: 3/20/2015 7:22:11 AM : Outperform Start Price: $4.92 OCRX Score: -95.16

There's just too much positive things going on @ this Company at the moment.

Leaderboard

Find the members with the highest scoring picks in OCRX.

Score Leader

sdhwang422

sdhwang422 (77.21) Score: +172.57

The Score Leader is the player with the highest score across all their picks in OCRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Beep636 43.82 2/23/2017 Outperform 5Y $0.62 +88.71% +5.30% +83.41 0 Comment
jasonrivera < 20 1/13/2016 Underperform 5Y $2.29 -48.91% +31.85% +80.76 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. drugtrader 95.64 2/10/2017 Outperform 5Y $0.63 +87.20% +7.96% +79.24 0 Comment
oscillation 72.53 2/2/2017 Outperform 5Y $0.62 +87.23% +9.51% +77.72 1 Comment
otherAquanaut 99.77 4/27/2017 Underperform 3M $1.26 -7.14% +4.41% +11.55 0 Comment
tradeseeker14 33.77 4/3/2017 Outperform NS $1.30 -10.00% +5.78% -15.78 0 Comment
karakartal < 20 3/9/2017 Outperform 5Y $1.36 -13.97% +5.38% -19.35 0 Comment
DoubleBagel 38.30 1/23/2017 Outperform 5Y $2.10 -44.29% +10.48% -54.76 0 Comment
sublimeinvestor 30.05 11/28/2016 Outperform 5Y $2.18 -46.43% +12.79% -59.23 0 Comment
Plasmidologist 31.21 11/28/2016 Outperform 5Y $2.18 -46.43% +12.80% -59.24 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBMOCapital < 20 1/6/2014 Outperform NS $14.78 -92.08% +35.96% -128.04 0 Comment
TrackStifel 94.61 12/30/2013 Outperform NS $12.40 -90.56% +35.66% -126.23 0 Comment

Featured Broker Partners